HK$4.63
3.74%
Hong Kong, Oct 02, 02:49 pm HKT. Closed.
Why the stock moved Why the stock moved Beta
ISIN
KYG6981F1090
Symbol
9996

Peijia Medical Stock price

HK$4.59
-0.35 7.09% 1M
-1.56 25.33% 6M
-1.43 23.71% YTD
-1.98 30.11% 1Y
-2.40 34.31% 3Y
-15.30 76.94% 5Y
-21.22 82.23% 10Y
-21.22 82.23% 20Y
Hong Kong, Closing price Fri, Oct 02 2026
-0.23 4.68%
ISIN
KYG6981F1090
Symbol
9996

Is Peijia Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$3.2b
Enterprise Value
HK$3.1b
Net debt
positive
Cash
HK$890.8m
Shares outstanding
674.7m
Valuation
P/E
negative
P/S | estimate
3.5 | 3.0
EV/Sales | estimate
3.4 | 2.8
EV/FCF | ex SBC
- | -
P/B
1.5
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
-6.7%
ROIC
-8.9%
Debt/Equity
0.4
Financials
Revenue | estimate
HK$917.6m | HK$1.1b
EBITDA
-
EBIT
HK$-172.4m
Net Income
HK$-165.0m
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
17.4% | 31.6%
EBITDA
-
EBIT
29.4%
Net Income
37.4%
Free Cash Flow
-
Margin
Gross
67.4%
EBITDA
-
EBIT
-18.8%
Net
-18.0%
Free Cash Flow | ex SBC
- | -
More
EPS
HK$-0.3
FCF per Share
-
Short interest
-
Employees
1k
Rev per Employee
HK$820.0k

Peijia Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Peijia Medical forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Peijia Medical forecast:

Buy
90%
Hold
10%

Financial data from Peijia Medical

Jun '26
+/-
%
918 918
17% 17%
100%
- Direct Costs 299 299
24% 24%
33%
619 619
14% 14%
67%
- Selling and Administrative Expenses 480 480
13% 13%
52%
- Research and Development Expense 266 266
4% 4%
29%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -172 -172
29% 29%
-19%
Net Profit -165 -165
37% 37%
-18%

In millions HKD.

Don't miss a Thing! We will send you all news about Peijia Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu and currently employs 1,022 full-time employees. The company went IPO on 2020-05-15. The firm primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The firm mainly conducts its businesses in the domestic market.

Head office Cayman Islands
CEO Dr. Zhang
Employees 1,022
Website www.peijiamedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today